See more : Sunridge International, Inc. (SNDZ) Income Statement Analysis – Financial Results
Complete financial analysis of Vineet Laboratories Limited (VINEETLAB.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vineet Laboratories Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- Jervois Global Limited (JRV.V) Income Statement Analysis – Financial Results
- George Weston Limited (WN.TO) Income Statement Analysis – Financial Results
- SAI.TECH Global Corporation (SAITW) Income Statement Analysis – Financial Results
- Epigenomics AG (EPGNY) Income Statement Analysis – Financial Results
- Wilson Learning Worldwide Inc. (9610.T) Income Statement Analysis – Financial Results
Vineet Laboratories Limited (VINEETLAB.BO)
About Vineet Laboratories Limited
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients and fine chemicals in India. It offers intermediates of lopinavir, ritonavir, efavirenz, nadolol, glimepiride, celecoxib, olanine, and other API intermediates; and fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.51B | 2.12B | 1.91B | 2.43B | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.23B | 1.83B | 1.59B | 2.13B | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 277.69M | 297.43M | 317.96M | 306.82M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 18.44% | 14.01% | 16.63% | 12.60% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 9.64M | 14.92M | 9.75M | 4.14M | 41.89K | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 25.26M | 25.49M | 14.24M | 2.39M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 34.89M | 40.41M | 23.99M | 6.53M | 41.89K | 0.00 | 0.00 | 0.00 |
| Other Expenses | 195.98M | 1.23M | 313.00K | 653.00K | -2.36K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 230.87M | 241.16M | 206.50M | 243.43M | 111.02K | 0.00 | 0.00 | 0.00 |
| Cost & Expenses | 1.46B | 2.07B | 1.80B | 2.37B | 111.02K | 0.00 | 0.00 | 0.00 |
| Interest Income | 354.00K | 1.23M | 1.62M | 462.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 47.81M | 26.58M | 14.89M | 20.55M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 25.19M | 23.73M | 20.16M | 18.07M | 171.86K | 161.14K | 52.52K | 22.82K |
| EBITDA | 67.32M | 77.83M | 134.47M | 85.32M | -111.02K | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | 4.47% | 3.33% | 6.72% | 3.25% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 46.81M | 57.16M | 111.46M | 63.39M | -111.02K | 0.00 | 0.00 | 0.00 |
| Operating Income Ratio | 3.11% | 2.69% | 5.83% | 2.60% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -43.18M | -36.86M | -18.01M | -22.81M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 3.63M | 20.30M | 93.46M | 40.58M | -111.02K | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.24% | 0.96% | 4.89% | 1.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -6.64M | 7.77M | 27.07M | 22.78M | -171.86K | 0.00 | 0.00 | 0.00 |
| Net Income | 10.27M | 12.53M | 66.39M | 17.80M | -111.02K | 0.00 | 0.00 | 0.00 |
| Net Income Ratio | 0.68% | 0.59% | 3.47% | 0.73% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 1.11 | 1.36 | 7.20 | 1.93 | -0.27 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 1.11 | 1.36 | 7.20 | 1.93 | -0.27 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 9.25M | 9.22M | 9.22M | 9.22M | 410.00K | 9.22M | 9.22M | 9.22M |
| Weighted Avg Shares Out (Dil) | 9.25M | 9.22M | 9.22M | 9.22M | 410.00K | 9.22M | 9.22M | 9.22M |
Source: https://incomestatements.info
Category: Stock Reports